Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma [Phase 1]

View source ↗

Summary

This clinical trial update reports that intralesional Ronkyla plus injection is being studied in a Phase 1 trial for superficial lipoma, with recruitment ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ronkyla

Snippet

Sponsor: Glonova Pharma Co., Ltd | Conditions: Lipoma, Submental Fullness | Phase 1 | Status: RECRUITING